Finanzielle Vergleiche Charles River Laboratories International, Inc. Deutsche Boerse AG
Aktien
939391
US1598641074
RV6
Biotechnologie
|
Markt geschlossen -
Deutsche Boerse AG
08:01:48 02.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 254.80 EUR | -2.49% |
|
-1.28% | +48.27% |
Hauptkonkurrenten
| Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 6.5 Mrd. | 42.13% | 52.64% | 28.56% | 20.88% | -0.99x | |
| 4.25 Mrd. | 30.41% | 24.81% | 20.15% | 17.36% | -3.18x | |
| 8.24 Mrd. | 14.53% | 21.7% | 10.28% | 4.9% | 1.58x | |
| 16.31 Mrd. | 8.34% | 13.38% | 32.9% | 4.79% | 3.63x | |
| 5.34 Mrd. | 5.37% | 8.37% | 29.84% | 16.27% | -5.99x | |
| 2.88 Mrd. | 24.74% | 28.07% | 5.94% | 4.75% | 1.77x | |
| 3.12 Mrd. | 22.53% | 31.44% | 11.9% | 8.13% | -1.19x | |
| 3.37 Mrd. | -39.59% | -48.95% | -5.88% | -5.1% | 6.99x | |
| 606 Mio. | -210.54% | -205.59% | -249.28% | - | 0.72x | |
| 3.69 Mrd. | 25.89% | 28.63% | 17.53% | 9.99% | -1.51x | |
| 2.53 Mrd. | 17.83% | 20.93% | 70.23% | 22.13% | -0.89x | |
| 498 Mio. | 32.27% | 31.52% | 16.97% | 14.74% | -3.83x | |
| 846 Mio. | -31.67% | -18.92% | - | - | 1.57x | |
| 294 Mio. | -18.56% | -24.05% | -9.34% | -9.05% | 8.22x | |
| 8.57 Mrd. | 6.51% | 14.79% | 9.61% | 4.34% | 2.22x | |
| 2.32 Mrd. | 33.73% | 37.59% | 35.53% | 27.02% | -1.18x | |
| 1.27 Mrd. | -19.27% | -3.71% | -38.64% | -6.61% | -65.61x | |
| 4.02 Mrd. | -3.59% | 19.77% | 15.46% | 6.99% | 1.98x | |
| Durchschnitt | 4.15 Mrd. | -3.27% | 1.8% | 0.1% | 8.85% | -3.09x | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | 5.26 Mrd. | 4.54% | 9.08% | 5.46% | 10.7% | -1.75x |
- Börse
- Aktien
- 939391 Aktie
- 939391 Aktie
- Sektor Charles River Laboratories International, Inc.
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
